Inflammation‐regulating cytokines such as TGF‐β and interleukin‐6 (IL‐6) are potent inducers of EMT and cancer stem cells (CSC) in breast cancer (Barcellos‐Hoff and Akhurst, 2009; Xie et al., 2012). This evidence concerns the gene IL6 and breast carcinoma.